Dechert’s life science team in France represents the sector’s companies—active in all areas of the life sciences, including pharmaceutical products, biotechnologies, medical devices, services, and establishments (clinics, pharmacies, analytical laboratories, research centers, and retirement homes). We also assist with investment funds as part of their investment in this sector.
Thanks to our legal teams of life science specialists in the United States, Europe, Asia, and the Middle East, we are particularly well-positioned to handle our clients’ most complex transnational matters. We take part in M&A transactions involving several jurisdictions, fund-raising, IPOs in France and abroad (notably Nasdaq), pan-European or international complex litigation, particularly concerning patents or product liability.
